Brainsway Ltd
BWAY11.800USD
+0.330+2.88%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
445.31MCap. mercado
113.69P/E TTM
Más Datos de Brainsway Ltd Compañía
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Información de la empresa
Símbolo de cotizaciónBWAY
Nombre de la empresaBrainsway Ltd
Fecha de salida a bolsaDec 24, 2006
Director ejecutivoMr. Hadar Levy
Número de empleados120
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 24
Dirección16 Hartum Street Rad Tower, 14Th Floor
CiudadJERUSALEM
Bolsa de valoresTel Aviv Stock Exchange
PaísIsrael
Código postal9777516
Teléfono97225813140
Sitio Webhttps://www.brainsway.com/
Símbolo de cotizaciónBWAY
Fecha de salida a bolsaDec 24, 2006
Director ejecutivoMr. Hadar Levy
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Moria (Ankri) Ben Soussan
Ms. Moria (Ankri) Ben Soussan
Vice President - Research & Development
Vice President - Research & Development
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Mr. Christopher Boyer
Mr. Christopher Boyer
Vice President - Global Marketing
Vice President - Global Marketing
--
--
Mr. Ido Marom
Mr. Ido Marom
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Aron Tendler, M.D.
Dr. Aron Tendler, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Moria (Ankri) Ben Soussan
Ms. Moria (Ankri) Ben Soussan
Vice President - Research & Development
Vice President - Research & Development
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2024
FY2023
FY2022
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
33.23M
81.01%
Other
7.79M
18.99%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Valor Equity Partners
11.13%
Masters Capital Management, L.L.C.
5.29%
Phoenix Financial Ltd
3.69%
Phoenix Investment and Finances Ltd
1.92%
Acadian Asset Management LLC
1.78%
Other
76.19%
Accionistas
Accionistas
Proporción
Valor Equity Partners
11.13%
Masters Capital Management, L.L.C.
5.29%
Phoenix Financial Ltd
3.69%
Phoenix Investment and Finances Ltd
1.92%
Acadian Asset Management LLC
1.78%
Other
76.19%
Tipos de accionistas
Accionistas
Proporción
Private Equity
11.13%
Hedge Fund
10.11%
Investment Advisor
5.43%
Investment Advisor/Hedge Fund
4.87%
Holding Company
3.69%
Individual Investor
2.71%
Pension Fund
0.46%
Research Firm
0.30%
Other
61.29%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
82
7.34M
38.87%
+585.20K
2025Q1
84
7.36M
38.96%
-890.13K
2024Q4
77
7.26M
38.54%
-2.72M
2024Q3
65
3.62M
21.68%
-5.03M
2024Q2
59
4.49M
26.92%
-3.10M
2024Q1
56
4.64M
27.89%
-3.35M
2023Q4
48
4.90M
29.50%
-2.87M
2023Q3
43
4.53M
27.32%
-3.32M
2023Q2
45
4.62M
27.86%
-2.51M
2023Q1
50
4.74M
28.65%
-2.28M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Valor Equity Partners
2.10M
11.13%
--
--
Jun 29, 2025
Masters Capital Management, L.L.C.
1.00M
5.29%
--
--
Mar 31, 2025
Phoenix Financial Ltd
697.26K
3.69%
+456.90K
+190.09%
Oct 18, 2024
Phoenix Investment and Finances Ltd
403.99K
2.14%
-78.73K
-16.31%
Mar 31, 2025
Acadian Asset Management LLC
336.58K
1.78%
-16.33K
-4.63%
Mar 31, 2025
Essex Investment Management Company, LLC
303.17K
1.6%
-2.28K
-0.75%
Mar 31, 2025
Renaissance Technologies LLC
298.26K
1.58%
-31.40K
-9.52%
Mar 31, 2025
Shulkin (Jonathan K.)
268.25K
1.42%
+268.25K
--
Nov 05, 2024
Gracias (Antonio J)
243.50K
1.29%
+243.50K
--
Nov 05, 2024
ARK Investment Management LLC
188.33K
1%
+12.74K
+7.26%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
ARK Israel Innovative Technology ETF
2.26%
ActivePassive International Equity ETF
0.02%
iShares Neuroscience and Healthcare ETF
0%
ARK Israel Innovative Technology ETF
Proporción2.26%
ActivePassive International Equity ETF
Proporción0.02%
iShares Neuroscience and Healthcare ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
